Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The pricing information below is based on manufacturer announcements and platform disclosures available as of December 2025
If symptoms persist beyond 5 to 7 days or worsen, contact your healthcare provider for evaluation
Clinical trial data demonstrates that this weight loss is substantial and durable
So, its important to diagnose it accurately for good treatment
Boehringer Ingelheim International GmbH Scope of Report GLP-1 Receptor Agonist Market Analysis by Segments Drug: Semaglutide Exenatide Lixisenatide Liraglutide Dulaglutide Others Route of Administration: Oral Parenteral Indication: Diabetes Obesity Others Distribution Channel: Hospital Pharmacies Retail Pharmacies Online Pharmacies Region: North America Latin America Europe Asia-Pacific Middle East & Africa Bibliography Pharmaceutical Executive
US$ 21.31
US$ 23.16
US$ 28.24
